Potential Producers of Biogenic Magnetic Nanoparticles Among Pathogenic and Opportunistic Microorganisms

Authors

DOI:

https://doi.org/10.20535/1810-0546.2015.3.61067

Keywords:

Magnetic field, Biogenic magnetic nanoparticles, Inflammation, pathogenic microorganisms, Magnetic hyperthermia, Targeted delivery

Abstract

Problems. The complicated forms of infection in inflammatory processes characterized by rising resistance of microorganisms to antibiotics, are forcing to find new treatments that would prevent development of pathogenic microorganisms, increased local immunity, and thus accelerated regenerative processes.

Objective. Classification of pathogenic and opportunistic microorganisms that may be potential producers of BMN, in terms of the location and properties of BMN using the methods of comparative genomics with the prospect of their subsequent use as the vectors for magnetically targeted delivery of drugs. This will make possible the use of the hyperthermia techniques for removal of pathogenic and opportunistic microorganisms that are capable of biomineralization BMN using for heating the cells directly intracellular BMN of these microorganisms.

Methods of implementation. The methods of paired and multiple sequence alignment were applied using a free access program “BLAST” of National Center for Biotechnology Information.

Results. It was revealed that strains such as E. coli (541-15), K. pneumoniae 342, C. perfringens str. 13, P. fluorescens are potential producers of crystalline magnetite and bacteria: S. aureus RF122, S. suis BM407, E. aerogenes KCTC 2190, K. pneumoniae RYC492, P. aeruginosa M18 can be producers of intracellular amorphous BMN. The power of magnetic dipole interaction between BMN of the bacteria and BMN of the tumors is in the range between 10-7–10-8 N.

Conclusions. It is explained the neutralization effect of pathogens by the method of magnetic hyperthermia due to the presence BMN, and it was proposed the use for the treatment of inflammatory processes not only antibiotic drugs, but also electromagnetic fields for those microorganisms which are producers of BMN.

It is shown that as vectors for targeted delivery of drugs should be used microorganisms with natural magnetic properties, making method targeted delivery of drugs safer and more efficient, and reduced its cost.

 

Author Biographies

Світлана Василівна Горобець, National Technical Institute of Ukraine "Kyiv Polytechnic Institute"

Svitlana V. Gorobets, Doctor of Engineering Sciences, Professor, Head of Department of Bioinformatics of the Faculty of Biotechnology and Bioengineering

Оксана Юріївна Горобець, National Technical Institute of Ukraine "Kyiv Polytechnic Institute"

Oksana Yu. Gorobets, Doctor of Physics and Mathematics, Full Professor, Professor at the Department of Bioinformatics of the Faculty of Biotechnology and Bioengineering

Катерина Олександрівна Бутенко, National Technical Institute of Ukraine "Kyiv Polytechnic Institute

Kateryna O. Butenko,  Engineer at the Department of Bioinformatics of the Faculty of Biotechnology and Bioengineering

References

V.N. Nikiforov, “Medical applications of magnetic nanoparticles”, Izvestija Akademii Inzhenernyh Nauk im. A.M. Prohorova, no. 1, pp. 23–34, 2013 (in Russian).

V.N. Nikiforov and N.A. Brusentsov, “Magnetic hyperthermia in oncology”, Medicinskaja Fizika, no. 2, pp. 51–59, 2007 (in Russian).

M. Bañobre-López et al., “Control of bacterial cells growths by magnetic hyperthermia”, IEEE Tran. Magn., vol. 49, no. 7, 2013. doi 10.1109/tmag.2013.2247384

T. Ikehara et al., “Effects of time varying strong magnetic field on release of cytosolic free Ca2+ from intracellular stores in cultural bov in eadrenal chromaff in cells”, Bioelectromagnetics, vol. 23, no. 7, pp. 505–515, 2002. doi 10.1002/bem.10043

S.V. Gorobets and O.Yu. Gorobets, “Function of biogenic magnetic nanoparticles in organisms”, Functional Materials, vol. 19, no. 1, pp. 18–26, 2012. doi/10.1002/adfm.v22.24

S.V. Gorobets et al., “Biomineralization of biogenic magnetic nanoparticles and their possible functions in cells of prokaryotes and eukaryotes”, in Dekker Encyclopedia of Nanoscience and Nanotechnology, 3rd ed. Taylor&Francis, 2014, pp. 300–306.

S.V. Petrov, General Surgery. Saint Petersburg, Russia: Lan, 1999, 672 p. (in Russian).

S.V. Zilina et al., “Enterobacteriaceae in the chronic in flammatory diseases of the skin and soft tissues”, Chelovek i Ego Zdorov’e [Kursk scientific andpractical bulletin], no. 1, pp. 58–63, 2008 (in Russian).

N. Tran et al., “Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus”, Int. J. Nanomed., vol. 5 pp. 277–283, 2010.

T. Haikarainen et al., “Magnetic properties and structural characterization of iron oxide nanoparticles formed by Streptococcus suis Dpr and four mutants”, J. Biol. Inorg. Chem., vol. 16 pp. 799–807, 2011. doi 10.1007/s00775-011-0781-z

M. Vainshtein et al., “New magnet-sensitive structures in bacterial and archaeal cells”, Biology of the Cell, vol. 94, pp. 29–35, 2002.

S.V. Gorobets et al., “The genetic basis of a fundamental mechanism in the biosynthesis nanomagnetite magnitactic and an aerobic microorganisms”, Visnyk Natsional'noho Chernivets'koho Universytetu. Biolohichni Systemy, vol. 5, no. 2, pp. 274–280, 2013 (in Ukrainian).

S.V. Gorobets et al., “Biomineralization of magnet nanoparticles with bacterial symbionts of man”, Medychni Perspektyvy, vol. 19, no. 2, pp. 4–12, 2014 (in Ukrainian).

M. Cronin et al., “High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting”, PLoS ONE, vol. 7, no. 1, 2012. doi:10.1371/journal.pone.0030940.

S. Sakaguchi et al., “Desulfovibrio magneticus sp. nov., a novel sulfate-reducing bacterium that produces intracellular single-domain-sized magnetiteparticles”, Int. J. System. Evolution. Microbiol., vol. 52, pp. 215–221, 2002.

A.A. Bharde et al., “Bacteria-mediated precursor-dependent biosynthesis of superparamagnetic iron oxide and iron sulfide nanoparticles”, Langmuir, vol. 24, no. 11, 2008. doi 10.1021/la704019p.

D.R. Heywood et al., “Controlled biosynthesis of Greigite (Fe3S4) in magnetotactic bacteria”, Naturwissenschaften, vol. 77, p. 536, 1990.

S. Mann et al., “Ultrastructure, morphology and organization of biogenic magnetite from sockeye salmon, Oncorhynchus nerka: implications for magnetoreception”, J. Exp. Biol., vol. 40, p. 35, 1988.

J. Dobson et al., “Magnetic field sand iron biomineralization in the human brain”, Fund. Res. Applications, vol. 5, p. 16, 1995.

P. Schultheiss-Grassi et al., “Analysis of magnetic material in the human heart, spleen and liver”, BioMetals, vol. 10, p. 351, 1997.

F. Brem et al., “Magnetic iron compounds in the human brain: a comparison of tumour and hippocampal tissue”, J. R. Soc. Interface, vol. 3, pp. 833–841, 2006. doi:10.1098/ rsif.2006.0133

V.F. Chehun et al., “Magnetic nanostructures in tumor cells application of scanning probemicroscopy to study the structural organization magnetosensitive phase in tumor cells”, Visnyk NAN Ukrayiny, no. 11, pp. 13–20, 2011 (in Ukrainian).

S.V. Gorobets et al., “Magnetic force microscopy atherosclerotic plaques”, Medychni Perspektyvy, vol. 19, no. 1, pp. 4–10, 2014 (in Ukrainian).

J. Dobson, “Nanoscale biogenic iron oxides and neurodegenerative disease”, FEBS Lett., vol. 496, pp. 1–5, 2001.

O.Yu. Gorobets et al., “Biomineralization and syntesis of biogenic magnetic nanoparticles and magnetosensitive inclusions in microorganisms and fungi”, Functional Mater., no. 4, pp. 15–21, 2014.

S.V. Gorobets et al., “Magnetic dipole interaction of endogenous magnetic nanoparticles with magnetic liposomes in the targeted drug delivery”, Biophysics, vol. 58, no. 3, pp. 488–494, 2013.

BLAST Assembled Genomes [Online]. Avaliable: http://blast.ncbi.nlm.nih.gov.

S. Patyar et al., “Bacteria in cancer therapy: a novel experimental strategy”, J. Biomed. Sci., vol. 17, pp. 21–30, 2010.

M. Kitagawaa et al., “Gastrointestinal stromal tumor in a patient with neurofibro-matosis: abscess formation in the tumor lead in to bacteremia and seizure”, Case. Rep. Gastroenterol., vol. 4, pp. 435–442, 2010. doi: 10.1159/000321523.

M.Q. Wei et al., “Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours”, Eur. J. Cancer, vol. 43, pp. 490–496, 2007. doi:10.1016/j.ejca.2006.10.005.

J. Berzofsky and А. Berkover, “Antigen-antibody interaction”, in Immunology, W. Paul, Ed. Moscow, Russia: Mir, 1989, p. 87 (in Russian).

Published

2015-07-03